🇺🇸 FDA
Pipeline program

A study in healthy people to test whether BI 3000202 affects how 2 other medicines (rosuvastatin and digoxin) are taken up in the body

1509-0014

Phase 1 other active

Quick answer

A study in healthy people to test whether BI 3000202 affects how 2 other medicines (rosuvastatin and digoxin) are taken up in the body for Healthy volunteer trial is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim International GmbH
Indication
Healthy volunteer trial
Phase
Phase 1
Modality
other
Status
active

Clinical trials